Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)

NCT05775848 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)

Interventions

DRUG: BBP-418 (ribitol)
OTHER: Placebo

Sponsor

ML Bio Solutions, Inc.